BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 166481)

  • 1. Effect of citrate and aminotriazole on matrical plates induced in hepatic microbodies.
    Gotoh M; Griffin C; Hruban Z
    Virchows Arch B Cell Pathol; 1975; 17(4):279-94. PubMed ID: 166481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of hepatic microbodies in rats treated with acetylsalicylic acid, clofibrate, and dimethrin.
    Hruban Z; Gotoh M; Slesers A; Chou SF
    Lab Invest; 1974 Jan; 30(1):64-75. PubMed ID: 4812810
    [No Abstract]   [Full Text] [Related]  

  • 3. Matrical inclusions induced by clofibrate in hepatic microbodies of rats fed 2-acetylaminofluorene.
    Tsukada H; Mochizuki Y; Gotoh M
    J Natl Cancer Inst; 1975 Feb; 54(2):519-23. PubMed ID: 1113332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrical inclusions of peroxisomes induced by clofibrate in preneoplastic hepatocytes of rats fed 3'-methyl-4-dimethyl-aminoazobenzene.
    Gotoh M; Mochizuki Y; Sawada N; Tsukada H
    Gan; 1982 Feb; 73(1):7-13. PubMed ID: 6288498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of microbodies in Morris hepatoma 9618A to clofibrate.
    Tsukada H; Mochizuki Y; Itabashi M; Gotoh M; Morris HP
    J Natl Cancer Inst; 1975 Jul; 55(1):153-8. PubMed ID: 169361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of clofibrate and 3-amino-1,2,4-triazole on liver catalase and lipid metabolism in mice.
    Jones GL; Neill AR
    Biochim Biophys Acta; 1982 Aug; 712(2):420-6. PubMed ID: 7126616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clofibrate application on morphology and enzyme content of liver peroxisomes.
    Goldenberg H; Hüttinger M; Kampfer P; Kramar R; Pavelka M
    Histochemistry; 1976 Feb; 46(3):189-96. PubMed ID: 1248951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential increase of hepatic peroxisomal, mitochondrial and microsomal carnitine acyltransferases in clofibrate-fed rats.
    Markwell MA; Bieber LL; Tolbert NE
    Biochem Pharmacol; 1977 Sep; 26(18):1697-702. PubMed ID: 901588
    [No Abstract]   [Full Text] [Related]  

  • 10. On the synthesis and degradation of the multiple forms of catalase in mouse liver: effects of aminotriazole and p-chlorophenoxyisobutric acid ethyl ester.
    Jones GL; Masters CJ
    Arch Biochem Biophys; 1978 Apr; 187(2):431-40. PubMed ID: 666320
    [No Abstract]   [Full Text] [Related]  

  • 11. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
    Azarnoff DL; Svoboda DJ
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofibrate-like effects of acetylsalicylic acid on peroxisomes and on hepatic and serum triglyceride levels.
    Ishii H; Suga T
    Biochem Pharmacol; 1979 Sep; 28(18):2829-33. PubMed ID: 497031
    [No Abstract]   [Full Text] [Related]  

  • 14. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
    Reddy J; Svoboda D
    Am J Pathol; 1971 Apr; 63(1):99-108. PubMed ID: 4323477
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds.
    Moody DE; Reddy JK
    Toxicol Appl Pharmacol; 1978 Aug; 45(2):497-504. PubMed ID: 705785
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 3-amino,1,2,4-triazole on plasma renin activity and renal peroxisomal enzymes in rats.
    Morimoto S; Matsumura Y; Abe R; Fukuhara A
    Jpn J Pharmacol; 1978 Oct; 28(5):793-6. PubMed ID: 723008
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of microperoxisomes in rat small intestinal mucosa to CPIB, a hypolipidemic drug.
    Svoboda DJ
    Biochem Pharmacol; 1976 Dec; 25(24):2750-2. PubMed ID: 1008899
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
    Reddy JK; Moody DE; Azarnoff DL; Rao MS
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental model of the peroxide toxicity of peroxisomes].
    Antonenkov VD; Pirozhkov SV; Popova SV
    Patol Fiziol Eksp Ter; 1987; (3):81-4. PubMed ID: 3627843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.